The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
Open accessAbstract
BACKGROUND: Cryptococcal meningitis is a leading cause of human immunodeficiency virus (HIV)-related death in sub-Saharan Africa. Whether a treatment regimen that includes a single high dose of liposomal amphotericin B would be efficacious is not known. METHODS: In this phase 3 randomized, controlled, noninferiority trial conducted in five African countries, we assigned HIV-positive adults with cryptococcal meningitis in a 1:1 ratio to receive either a single high dose of liposomal amphotericin B (10 mg per kilogram of body weight) on day 1 plus 14 days of flucytosine (100 mg per kilogram per day) and fluconazole (1200 mg per day) or the current World Health Organization-recommended treatment, which includes amphotericin B deoxycholate (1 mg per kilogram per day) plus flucytosine (100 mg per kilogram per day) for 7 days, followed by fluconazole (1200 mg per day) for 7 days (control). The primary end point was death from any cause at 10 weeks; the trial was powered to show noninferiority at a 10-percentage-point margin. RESULTS: CFU per milliliter per day in the control group. Fewer participants had grade 3 or 4 adverse events in the liposomal amphotericin B group than in the control group (50.0% vs. 62.3%). CONCLUSIONS: Single-dose liposomal amphotericin B combined with flucytosine and fluconazole was noninferior to the WHO-recommended treatment for HIV-associated cryptococcal meningitis and was associated with fewer adverse events. (Funded by the European and Developing Countries Clinical Trials Partnership and others; Ambition ISRCTN number, ISRCTN72509687.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis
Rajasingham, R., Smith, R. M., Park, B. J., Jarvis, J. N., Govender, N. P., Chiller, T. M., Denning, D. W., Loyse, A., & Boulware, D. R. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30243-8 · Cited by 1,861
Self-citationCombination Antifungal Therapy for Cryptococcal Meningitis
Day, J. N., Chau, T. T. H., Wolbers, M., Mai, P. P., Dung, N. T., Mai, N. H., Phu, N. H., Nghia, H. D., Phong, N. D., Thai, C. Q., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1110404 · Cited by 545
Self-citationTiming of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
Boulware, D. R., Meya, D. B., Muzoora, C., Rolfes, M. A., Huppler Hullsiek, K., Musubire, A., Taseera, K., Nabeta, H. W., Schutz, C., Williams, D. A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312884 · Cited by 497
Self-citationCombination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial
Brouwer, A. E., Rajanuwong, A., Chierakul, W., Griffin, G. E., Larsen, R. A., White, N. J., & Harrison, T. S. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16301-0 · Cited by 470
Self-citationSingle-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Sundar, S., Chakravarty, J., Agarwal, D., Rai, M., & Murray, H. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903627 · Cited by 434
Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa
Molloy, S. F., Kanyama, C., Heyderman, R. S., Loyse, A., Kouanfack, C., Chanda, D., Mfinanga, S., Temfack, E., Lakhi, S., Lesikari, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710922 · Cited by 396
Self-citationGroll, A. H., Giri, N., Petraitis, V., Petraitiene, R., Candelario, M., Bacher, J. S., Piscitelli, S. C., & Walsh, T. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315643 · Cited by 373
Johnson, P. C., Wheat, L. J., Cloud, G. A., Goldman, M., Lancaster, D., Bamberger, D. M., Powderly, W. G., Hafner, R., Kauffman, C. A., Dismukes, W. E., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-2-200207160-00008 · Cited by 367
Adjunctive Dexamethasone in HIV-Associated Cryptococcal Meningitis
Beardsley, J., Wolbers, M., Kibengo, F. M., Ggayi, A.-B. M., Kamali, A., Cuc, N. T. K., Binh, T. Q., Chau, N. V. V., Farrar, J., Merson, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1509024 · Cited by 315
Self-citationAdult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases
Jarvis, J. N., Meintjes, G., Williams, A., Brown, Y., Crede, T., & Harrison, T. S. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-67 · Cited by 266
Self-citationHamill, R. J., Sobel, J. D., El‐Sadr, W., Johnson, P. C., Graybill, J. R., Javaly, K., & Barker, D. E. (2010) · Clinical Infectious Diseases · doi:10.1086/653606 · Cited by 175
Carmona, S., Bor, J., Nattey, C., Maughan-Brown, B., Maskew, M., Fox, M. P., Glencross, D. K., Ford, N., & MacLeod, W. B. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy045 · Cited by 169
Clinical Pharmacokinetics, Pharmacodynamics, Safety and Efficacy of Liposomal Amphotericin B
Groll, A. H., Rijnders, B. J. A., Walsh, T. J., Adler‐Moore, J., Lewis, R. E., & Brüggemann, R. J. M. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz076 · Cited by 143
Osler, M., Hilderbrand, K., Goemaere, E., Ford, N. P., Smith, M., Meintjes, G., Kruger, J., Govender, N. P., & Boulle, A. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1140 · Cited by 138
Self-citationLee, J. W., Amantea, M., Francis, P. A., Navarro, E. E., Bacher, J. D., Pizzo, P. A., & Walsh, T. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.713 · Cited by 134
Vogelsinger, H., Weiler, S., Djanani, A., Kountchev, J., Bellmann-Weiler, R., Wiedermann, C. J., & Bellmann, R. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl141 · Cited by 120
Bicanic, T. A., Bottomley, C., Loyse, A., Brouwer, A. E., Muzoora, C. K., Taseera, K., Jackson, A., Phulusa, J., Hosseinipour, M. C., van der Horst, C., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01698-15 · Cited by 120
Self-citationAdler‐Moore, J., Lewis, R. E., Brüggemann, R. J. M., Rijnders, B. J. A., Groll, A. H., & Walsh, T. J. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz064 · Cited by 90
Jackson, A. T., Nussbaum, J. C., Phulusa, J., Namarika, D., Chikasema, M., Kanyemba, C., Jarvis, J. N., Jaffar, S., Hosseinipour, M. C., van der Horst, C., et al. (2012) · AIDS · doi:10.1097/qad.0b013e328354b419 · Cited by 86
Self-citationJarvis, J. N., Leeme, T. B., Molefi, M., Chofle, A. A., Bidwell, G., Tsholo, K., Tlhako, N., Mawoko, N., Patel, R. K. K., Tenforde, M. W., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy515 · Cited by 86
Self-citationTenforde, M. W., Gertz, A. M., Lawrence, D. S., Wills, N. K., Guthrie, B. L., Farquhar, C., & Jarvis, J. N. (2020) · Journal of the International AIDS Society · doi:10.1002/jia2.25416 · Cited by 77
Self-citationTenforde, M. W., Mokomane, M., Leeme, T., Patel, R. K. K., Lekwape, N., Ramodimoosi, C., Dube, B., Williams, E. A., Mokobela, K. O., Tawanana, E., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix430 · Cited by 67
Self-citationO’Connor, L., Livermore, J., Sharp, J., Goodwin, J., Gregson, L., Howard, S. J., Felton, T., Schwartz, J. A., Neely, M. N., Harrison, T. S., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit164 · Cited by 59
Self-citationGarcía, A. C., Adler‐Moore, J., & Proffitt, R. T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2327-2332.2000 · Cited by 51
Lawrence, D. S., Youssouf, N. F., Molloy, S. F., Alanio, A., Alufandika, M., Boulware, D. R., Boyer‐Chammard, T., Chen, T., Dromer, F., Hlupeni, A., et al. (2018) · Trials · doi:10.1186/s13063-018-3026-4 · Cited by 46
Self-citationLestner, J. M., McEntee, L., Johnson, A., Livermore, J., Whalley, S., Schwartz, J., Perfect, J. R., Harrison, T. S., & Hope, W. W. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00090-17 · Cited by 38
Self-citationHope, W. W., Goodwin, J., Felton, T., Ellis, M. E., & Stevens, D. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00933-12 · Cited by 35
Self-citationGubbins, P. O., Amsden, J. R., McConnell, S. A., & Anaissie, E. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01448-08 · Cited by 35
Tenforde, M. W., Mokomane, M., Leeme, T., Tlhako, N., Tsholo, K., Ramodimoosi, C., Dube, B., Mokobela, K. O., Tawanana, E., Chebani, T., et al. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.06.013 · Cited by 19
Self-citation
Cited by
The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis
Rajasingham, R., Govender, N. P., Jordan, A., Loyse, A., Shroufi, A., Denning, D. W., Meya, D. B., Chiller, T. M., & Boulware, D. R. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00499-6 · Cited by 587
Self-citationChang, C. C., Harrison, T. S., Bicanic, T. A., Chayakulkeeree, M., Sorrell, T. C., Warris, A., Hagen, F., Spec, A., Oladele, R., Govender, N. P., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00731-4 · Cited by 326
Self-citation
Metadata
- Authors
- Jarvis, J. N., Lawrence, D. S., Meya, D. B., Kagimu, E., Kasibante, J., Mpoza, E., Rutakingirwa, M. K., Ssebambulidde, K., Tugume, L., Rhein, J., Boulware, D. R., Mwandumba, H. C., Moyo, M., Mzinganjira, H., Kanyama, C., Hosseinipour, M. C., Chawinga, C., Meintjes, G., Schutz, C., Comins, K., Singh, A., Muzoora, C., Jjunju, S., Nuwagira, E., Mosepele, M., Leeme, T., Siamisang, K., Ndhlovu, C. E., Hlupeni, A., Mutata, C., van Widenfelt, E., Chen, T., Wang, D., Hope, W., Boyer-Chammard, T., Loyse, A., Molloy, S. F., Youssouf, N., Lortholary, O., Lalloo, D. G., Jaffar, S., & Harrison, T. S.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2022-03-24
- Volume
- 386
- Issue
- 12
- Pages
- 1109-1120
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4220750098
- Cited by
- 286
- References
- 29
- FWCI
- 34.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.